Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,908,153 papers from all fields of science
Search
Sign In
Create Free Account
garenoxacin
Known as:
1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Broader (3)
Anti-Bacterial Agents
Fluoroquinolones
Topoisomerase II Inhibitors
Narrower (1)
BMS 284756
Garenoxacin Mesylate
Garenoxacin:Susc:Pt:Isolate:OrdQn
Garenoxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion
Garenoxacin:Susc:Pt:Isolate:OrdQn:MIC
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
An Optimal Approach for Fluoroquinolone Garenoxacin Prophylaxis in Patients with Hematological Malignancies and Chemotherapy-induced Neutropenia
T. Mushino
,
N. Hanaoka
,
+6 authors
T. Sonoki
2017
Corpus ID: 64364678
Antibiotic prophylaxis such as that with fluoroquinolone reportedly reduces infectious episodes in patients receiving…
Expand
2016
2016
Sitafloxacinに対する非定型菌(2009年~2014年分離株)の感受性調査結果および2009年,2012年に分離された一般細菌の感受性推移の検討
天野 綾子
,
岸 直子
,
+6 authors
水野 正巳
2016
Corpus ID: 209548432
Review
2016
Review
2016
[Susceptibility of clinically-isolated bacteria strains to respiratory quinolones and evaluation of antimicrobial agent efficacy by Monte Carlo simulation].
T. Kosaka
,
Yukiji Yamada
,
+6 authors
N. Fujita
The Japanese Journal of Antibiotics
2016
Corpus ID: 19124973
Respiratory quinolones (RQs) are broad-spectrum antimicrobial agents used for the treatment of a wide variety of community…
Expand
2016
2016
In vitro activity of sitafloxacin against atypical bacteria (2009-2014) and comparison between susceptibility of clinical isolates in 2009 and 2012.
Ayako Amano
,
N. Kishi
,
+6 authors
Masami Mizuno
The Japanese Journal of Antibiotics
2016
Corpus ID: 52293176
In vitro activities of sitafloxacin (STFX) along with fluoroquinolones (levofloxacin (LVFX), moxifloxacin (MFLX), garenoxacin…
Expand
2016
2016
Preparation method for garenoxacin and intermediate thereof
张孝清
,
刘宝
,
包金远
,
唐鲁
2016
Corpus ID: 103579038
The invention provides a preparation method for garenoxacin and an intermediate thereof. The preparation method comprises the…
Expand
2015
2015
Pharmacokinetic study of garenoxacin in severe renal failure patients.
Y. Yamagishi
,
M. Hagihara
,
Y. Hamada
,
Yukihiro Kimura
,
H. Imai
,
H. Mikamo
The Japanese Journal of Antibiotics
2015
Corpus ID: 34073216
Garenoxacin is a type of fluoroquinolone antibacterial agents. Previous studies have suggested that garenoxacin 400 mg once daily…
Expand
2015
2015
Garenoxacin as a prophylactic anti-infective in hydropneumothorax: a case study report
S. Haider
,
A. Hajare
,
K. Krishnaprasad
,
A. Bhargava
2015
Corpus ID: 73033107
Pneumothorax appears to be a common clinical state. Iatrogenic pneumothorax occurs commonly after procedures such as…
Expand
2014
2014
GARENOXACIN IN SKIN & SKIN STRUCTURE INFECTIONS COMPLICATED BY BEAR BITE
M. Pukar
,
A. Hajare
,
K. Krishnaprasad
,
A. Bhargava
2014
Corpus ID: 73236388
Animal bites have always been a common problem to humans. The incidence of resistant organisms is also increasing in the…
Expand
2014
2014
Garenoxacin in uncomplicated urinary tract infection - A case study report
M. Pukar
,
J. Shah
,
A. Hajare
,
K. Krishnaprasad
,
A. Bhargava
2014
Corpus ID: 73228757
Urinary tract infection (UTI) is a global problem which has increased the morbidity and mortality in both men and women…
Expand
2009
2009
The Synthesis of Garenoxacin
M. Yaqin
2009
Corpus ID: 100140689
OBJECTIVE To prove synthetic procedure of Garenoxacin.METHODSGarenoxacin was synthesized from 1(R)-methyl -5-Bromo-1H-isoindole…
Expand